Benadryl 8 mg acrivastine capsules

Benadryl is a globally recognized antihistamine brand used to treat allergy symptoms. The specific product shown is Benadryl 8 mg capsules containing acrivastine, which is commonly marketed in Europe. Originally developed by the American pharmacist Robert McNeil in the late 19th century, the brand became a staple of Johnson & Johnson's consumer health portfolio for decades.

In recent years, the brand transitioned to Kenvue Inc., a dedicated consumer health company spun off from Johnson & Johnson in 2023. As of late 2025, Kenvue is in the process of being acquired by Kimberly-Clark Corporation, a major American multinational consumer goods company. This acquisition is expected to finalize in the latter half of 2026, making Kimberly-Clark the ultimate parent company of the brand. Manufacturing occurs in various global facilities, with the Danish market specifically served by McNeil Denmark ApS.